Nat. Immunol. 2005 Nov
Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T, Matsumoto K, Takeuchi O, Akira S
Abstract
Transforming growth factor-beta-activated kinase 1 (TAK1) has been linked to interleukin 1 receptor and tumor necrosis factor receptor signaling. Here we generated mouse strains with conditional expression of a Map3k7 allele encoding part of TAK1. TAK1-deficient embryonic fibroblasts demonstrated loss of responses to interleukin 1beta and tumor necrosis factor. Studies of mice with B cell-specific TAK1 deficiency showed that TAK1 was indispensable for cellular responses to Toll-like receptor lig
...[more]ands, CD40 and B cell receptor crosslinking. In addition, antigen-induced immune responses were considerably impaired in mice with B cell-specific TAK1 deficiency. TAK1-deficient cells failed to activate transcription factor NF-kappaB and mitogen-activated protein kinases in response to interleukin 1beta, tumor necrosis factor and Toll-like receptor ligands. However, TAK1-deficient B cells were able to activate NF-kappaB but not the kinase Jnk in response to B cell receptor stimulation. These results collectively indicate that TAK1 is key in the cellular response to a variety of stimuli.
[less]
Mesh Headings:
Animals, Antigens, CD40, B-Lymphocytes, Embryo, Mammalian, Fibroblasts, Gene Deletion, Immunity, Innate, Interleukin-17, Lymphopoiesis, MAP Kinase Kinase Kinases, Membrane Glycoproteins, Mice, Mice, Mutant Strains, NF-kappa B, Receptors, Antigen, B-Cell, Receptors, Cell Surface, Toll-Like Receptors, Tumor Necrosis Factor-alpha